Notice: ASA extends its thoughts and condolences to those affected by the disaster in Oklahoma. Donations to help aid this relief can be made through the American Red Cross website.

>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS
>

FDA MEDWATCH ALERTS

RSS

May 20, 2013

All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility: Recall - Lack Of Sterility Assurance

Summary:

All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility

May 14, 2013

Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses

Summary:

Zolpidem Containing Products Drug Safety Communication

May 09, 2013

The Compounding Shop: FDA News Release - Lack of Sterility Assurance of Drug Products

Summary:

The Compounding Shop FDA News Release Lack of Sterility

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-13CE

... Read more »

Single Copies, Member Price: $360

What's New

Learn the latest information ASA members need to know and stay current on events impacting the anesthesia community by reading this section.

16–20 of 20 results
Show:
1|
2|

Wednesday, January 23, 2013

Fungal Meningitis Outbreak Information

ASA brings you the latest fungal meningitis outbreak information.

view details »

Wednesday, January 02, 2013

2012 Refresher Course Lecture outlines now available

Couldn't make it to this year's annual meeting? Experience the ANESTHESIOLOGY™ 2012 annual meeting anytime, anywhere with the 2012 Refresher Course Lecture outlines. Available as a downloadable link and flash drive, the 2012 RCLs are perfect for doing research, brushing up on skills and can be used a a reference while teaching. Learn more and order today.

view details »

Saturday, December 29, 2012

Earn a Certificate in Business Administration

2013 Certificate in Business Administration

view details »

Monday, October 15, 2012

Statement on Fungal Meningitis Outbreak: FDA Advises Additional Patient Notification

Statement on Fungal Meningitis Outbreak FDA Advises Additional Patient Notification

view details »